Preferred Label : Buschke-ollendorff syndrome;
Symbol : BOS;
CISMeF acronym : BOS;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Dermatofibrosis, disseminated, with osteopoikilosis; Dermatofibrosis lenticularis disseminata with osteopoikilosis; Osteopathia condensans disseminata; DERMATOOSTEOPOIKILOSIS;
Included titles and symbols : Osteopoikilosis, isolated; Dermatofibrosis lenticularis disseminata, isolated; Osteopoikilosis with melorheostosis;
Description : Buschke-Ollendorff syndrome is an autosomal dominant connective tissue disorder manifest
by multiple subcutaneous nevi or nodules. They may be either elastin-rich (elastoma)
or collagen-rich (dermatofibrosis lenticularis disseminata) on histologic examination.
The lesions are usually nontender and firm. Affected individuals also have osteopoikilosis
(OPK), literally meaning 'spotted bones,' which are osteosclerotic foci that occur
in the epiphyses and metaphyses of long bones, wrist, foot, ankle, pelvis, and scapula.
Some individuals have both skin and bone manifestations, whereas others may lack skin
or bone manifestations. Some individuals may also have melorheostosis (155950), which
is characterized by 'flowing' hyperostosis of the cortex of tubular bones. Most reported
cases of BOS and OPK are benign, and the bone lesions are found incidentally, although
some patients may have joint pain (reviews by Hellemans et al., 2004 and Zhang et
al., 2009).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the LEM domain-containing-3 gene (LEMD3, 607844.0001);
Prefixed ID : #166700;
Origin ID : 166700;
UMLS CUI : C0265514;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
False automatic mappings
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)